Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

STADA Arzneimittel AG - Filing #6743034

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	3.468.340 EUR	—	—	—	—	—	3.322.851 EUR	—	—	—	—	—	—
Current assets	—	2.288.605 EUR	—	—	—	—	—	1.935.346 EUR	—	—	—	—	—	—
Non-current liabilities	—	3.053.860 EUR	—	—	—	—	—	2.930.891 EUR	—	—	—	—	—	—
Current liabilities	—	1.487.541 EUR	—	—	—	—	—	1.309.955 EUR	—	—	—	—	—	—
Revenue	—	—	—	—	—	—	3.249.451 EUR	—	3.010.315 EUR	—	—	—	—	—
Profit (loss)	16,871 EUR	—	246,939 EUR	—	—	246,939 EUR	263,810 EUR	—	181,899 EUR	—	167,314 EUR	14,585 EUR	167,314 EUR	—
Other comprehensive income	215,000 EUR	—	3,206 EUR	4,419 EUR	73,087 EUR	80,673 EUR	80,888 EUR	—	124,288 EUR	127,159 EUR	2,761 EUR	184,000 EUR	124,104 EUR	5,816 EUR
Comprehensive income	—	—	—	—	—	—	344,698 EUR	—	57,611 EUR	—	—	—	—	—